Abstract
Background
Medication management, a complex yet essential part of patient care, requires that clinicians and patients understand indication, dosage, frequency, and adverse effects in order to maximize benefits and minimize errors, as well as to transition patients from hospital to home. Clinical pharmacists improve care transitions and safety by interacting with patients, prescribers, and nurses on medication management and self-care. However, little is known on the use of clinical pharmacists on interdisciplinary teams at the unit level within orthopedics.
Questions/Purposes
This study sought to measure the impact of unit-based clinical pharmacists on patient perceptions of communication specific to medication during hospitalization at an orthopedic specialty hospital and on the frequency of medication errors.
Methods
A retrospective, quasi-experimental, two-group evaluative design with nonequivalent controls was used. Consumer Assessment of Healthcare Providers and Systems (HCAHPS) data on six inpatient units was analyzed 6 months before and 6 months after assignment of clinical pharmacists to half these units. Data specific to questions that measure quality of communication as well as medication understanding were analyzed. Additionally, data on medication error frequency were collected and compared between units with and without clinical pharmacists.
Results
A total of 2022 surveys were analyzed. The percentage of patients who reported receipt of medication information and medication understanding increased significantly after the implementation of unit-based clinical pharmacists. Comparison of intervention and non-intervention groups showed no statistically significant difference in the frequency of medication errors.
Conclusion
Results suggest that a clinical pharmacist assigned to an inpatient unit in orthopedics significantly influences patient perceptions of communication about and understanding of their medications.
Similar content being viewed by others
References
Boulding W, Glickman SW, Manary MP, Schulman KA, Staelin R. Relationship between patient satisfaction with inpatient care and hospital readmission within 30 days. Am J Manag Care. 2011;17(1):41–48.
Brantley AF, Rossi DM, Barnes-Warren S, Francisco JC, Schatten I, Dave V.Bridging gaps in care: implementation of a pharmacist-led transitions-of-care program. Am J Health Syst Pharm. 75(5 Supplement 1):S1–S5. https://doi.org/10.2146/ajhp160652.
Kaboli PJ1, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–964.
Kennedy JM, van Rij AM, Spears GF, Pettigrew RA, Tucker IG. Polypharmacy in a general surgical unit and consequences of drug withdrawal. Br J Clin Pharmacol. 2000;49:353–362.
Kripalani S, Roumie CL, Dalal AK, et al. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157(1):1–10:https://doi.org/10.7326/0003-4819-157-1-201207030-00003
Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282(3):267–270.
Levine RE, Fowler FJ Jr, Brown JA. Role of cognitive testing in the development of the CAHPS Hospital Survey. Health Serv Res. 2005;40(6 Pt 2):2037–2056:https://doi.org/10.1111/j.1475-6773.2005.00472.x
National Coordinating Council for Medication Error Reporting and Prevention. Types of medication errors. February 20, 2001. Available from http://www.nccmerp.org/types-medication-errors
Phatak, A, Prusi R, Ward B, et al. Impact of pharmacist involvement in the transitional care of high-risk patients through medication education, and post discharge call-backs (IPITCH study). J Hosp Med. 2016;11(1):39–44.
Reichard, JS, Savage, S, Eckel SE. Pharmacy-initiated transition of care services: an opportunity to impact patient satisfaction. Hosp Pharm. 2015;50 (10):911-917:https://doi.org/10.1310/hpj5010-911
Renaudin P, Coste A, Audurier Y, et al. Clinical, economic and organizational impact of the clinical pharmacist in an orthopedic and trauma surgery department. J Patient Saf. 2018: 1–7. doi: https://doi.org/10.1097/PTS.0000000000000539
Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166(5):565–571. doi: https://doi.org/10.1001/archinte.166.5.565
Smythe MA, Shah PP, Spiteri TL, Lucarotti RL, Begle RL. Pharmaceutical care in medical progressive care patients. Ann Pharmacother. 1998;32(3):294–299.
Tran T, Taylor SE, Hardidge A, Mitri E, George J, Elliott RA. The prevalence and nature of medication errors and adverse events related to preadmission medications when patients are admitted to an orthopedic inpatient unit: an observational study. Ann Pharmacother. 2019;53(3):252–260. https://doi.org/10.1177/1060028018802472
Weiner BK, Venarske J, Yu M, Mathis K. Towards the reduction of medication errors in orthopedics and spinal surgery: outcomes using a pharmacist-led approach. Spine (Phila Pa 1976). 2008;33:104–107. https://doi.org/10.1097/BRS.0b013e31815e3a5d.
Ziaeian B, Araujo KL, Van Ness PH, Horwitz LI. Medication reconciliation accuracy and patient understanding of intended medication changes on hospital discharge. J Gen Intern Med. 2012;27(11):1513–1520. doi:https://doi.org/10.1007/s11606-012-2168-4
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Kelly Guerin, PharmD, BCPS, Patricia Quinlan, PhD, MPA, RN, CPHQ, Robert Wessolock, PharmD, MS, RPh, Stephanie Goldberg, MSN, RN, NEA-BC, and Patricia W. Stone, PhD, RN, FAAN, declare that they have no conflicts of interest. Joseph T. Nguyen, MPH, reports a grant to his institution from the Clinical Translational Science Center (CTSC), National Center for Advancing Translational Sciences (NCATS), grant #UL1-RR024996, outside the submitted work. The content is solely the responsibility of the authors and does not necessarily represent the official views of NCATS.
Human/Animal Rights
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013.
Informed Consent
Informed consent was waived from all patients for being included in this study.
Required Author Forms
Disclosure forms provided by the authors are available with the online version of this article.
Additional information
Level of Evidence: Level III: Retrospective therapeutic study
Electronic supplementary material
ESM 1
(PDF 73 kb)
Rights and permissions
About this article
Cite this article
Guerin, K., Quinlan, P., Wessolock, R. et al. Impact of a Unit-Based Clinical Pharmacist on Communication of Medication Information in an Orthopedic Hospital. HSS Jrnl 16 (Suppl 2), 333–338 (2020). https://doi.org/10.1007/s11420-019-09739-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11420-019-09739-2